高级检索

    用石墨烯/聚二烯丙基二甲基氯化铵复合修饰电极为工作电极的循环伏安法同时测定人血清中尼莫地平和硝苯地平的含量

    Simultaneous Determination of Nimodipine and Nifedipine in Human Serum by Cyclic Voltammetry Using Graphene/Polydiallyl Dimethyl Ammonium Chloride Composite Modified Electrode as Working Electrode

    • 摘要: 用聚二烯丙基二甲基氯化铵(PDDA)作为一种绿色还原剂还原氧化石墨(GO)制得石墨烯(GR),并进一步制得GR/PDDA复合物。将0.5 g·L-1 GR/PDDA悬浮液均匀滴涂于经预处理的玻碳电极(GCE)表面,于红外灯下照射烘干,即得GR/PDDA/GCE复合修饰电极。用傅里叶红外光谱仪对所合成的复合物进行表征,证实了合成是成功的。用循环伏安法表征了该修饰电极的电化学特性,证明了GCE表面的GR/PDDA镀层不仅增加了电极的表面积,而且加速了电荷传导速率。在pH 6.0的磷酸氢二钠-柠檬酸缓冲溶液中,研究了尼莫地平(NM)和硝苯地平(NF)在复合修饰电极上的电化学行为,结果表明,两者依次在-0.444,-0.737 V处出现较灵敏的还原峰,并且NM和NF的浓度在1.0×10-6~1.4×10-4mol·L-1,4.0×10-7~2.6×10-4mol·L-1内分别与其还原峰电流呈线性关系。检出限(3s)分别为3.9×10-7mol·L-1和5.6×10-8mol·L-1。用循环伏安法可实现人血清中此2种血管疾病治疗药物的同时测定。

       

      Abstract: Graphene (GR) and still further a composite material of GR/PDDA were prepared from graphite oxide (GO) with the green reductant, polydiallyl dimethyl ammonium chloride (PDDA). A suspension of 0.5 g·L-1 GR/PDDA in water was applied onto the surface of pretreated GCE dropwise, and dried under radiation of infrared lamp, thus to obtain the composite modified electrode of GR/PDDA/GCE. The composite material was characterized by FTIR, showing that the synthesis come out all right. The electrochemical features of the composite modified electrode were studied by CV, demonstrating that coating of GR/PDDA on GCE not only increased the surface area of the modified electrode but also accelerated the speed of transference of electric charges. Furthermore, electrochemical behaviors of nimodipine (NM) and nifedipine (NF), at the composite modified electrode were studied in buffer solution of dissodium hydrogen phosphate and citric acid at pH 6.0. It was found that sensitive reduction peaks at -0.444 V (for NM) and at -0.737 V (for NF) were observed and linear relationships between values of reduction peak current and concentration of NM and NF were obtained in the ranges of 1.0×10-6 to 1.4×10-4mol·L-1 and 4.0×10-7 to 2.6×10-4mol·L-1 respectively. Detection limits (3s) found were 3.9×10-7mol·L-1 (for NM) and 5.6×10-8mol·L-1 (for NF). Simultaneous CV determination of NM and NF (2 commonly used drugs for blood vessel diseases) in human serum samples was shown to be feasible.

       

    /

    返回文章
    返回